The GLP-1 Effect: How Weight-Loss Drugs Are Changing the Business of Healthcare @cheddar
The GLP-1 Effect: How Weight-Loss Drugs Are Changing the Business of Healthcare  @cheddar
Uploaded June 2026 | Updated September 2026, 2 weeks ago
America's GLP-1 boom is reshaping healthcare. SHARx co-founder Paul Pruitt explains who pays, why costs are surging, and what comes next.

Connect with Cheddar!
On Facebook: facebook.com/cheddar
On Instagram: instagram.com/cheddar
On the web: cheddar.com
In your inbox: need2know.cheddar.com/subscribe
The GLP-1 Effect: How Weight-Loss Drugs Are Changing the Business of HealthcareWhats next for Trumps Tesla?Theyre Watching From Orbit: How Hawkeye 360 Is Redefining National Security From SpaceNYCs food future is being written on rooftops and in high-tech labs🫜🍅Will New York’s BNPL Crackdown Reshape Short Term Consumer Credit?Why One Expert Said Apple Just Disrupted the Entire Computing IndustryMarkets on Edge: Trump’s Iran Strategy, Oil at $150 & Recession WarningsA breakthrough invention that was flawed🧤😕 #tech #inventionA Hostile Bid, a Fed Rate Cut, and a Shaky Economy: This Week’s Biggest MovesPotterheads, this one is for you🪄🧙🔮
Cheddar |

The GLP-1 Effect: How Weight-Loss Drugs Are Changing the Business of Healthcare

SHARE TO X SHARE TO REDDIT SHARE TO FACEBOOK WALLPAPER